Similar to its ability to enhance the anti-tumor effect of NK cells and γδ T cells [39, 40], IL-15 also enhanced the anti-tumor effect of DNTs against NSCLC both in vitro and in vivo (Fig. 6). This evidence concerns the gene IL15 and neoplasm.